Clinical Trials Directory

Trials / Completed

CompletedNCT01541293

Intrauterine Lidocaine for Laminaria

Intrauterine Lidocaine for Pain Control During Laminaria Insertion Prior to Dilation & Evacuation (D&E)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
72 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study to investigate whether instilling a small amount of liquid lidocaine into the uterus will decrease pain felt by women during laminaria insertions done for cervical dilation prior to second trimester abortion. The investigators hypothesize that women who receive intrauterine lidocaine in addition to a paracervical block will experience less pain than women who receive only a paracervical block.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine100mg of liquid lidocaine, single dose, instilled into the uterine cavity via a flexible trans-cervical catheter immediately prior to laminaria insertion.
DRUGNormal Saline5mL of normal saline, instilled into the uterus via a flexible trans-cervical catheter immediately prior to laminaria insertion.

Timeline

Start date
2012-09-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2012-02-29
Last updated
2014-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01541293. Inclusion in this directory is not an endorsement.